These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9426852)

  • 1. Abnormal serotonin metabolism in long-term hemodialysis and CAPD patients.
    Cheng CH; Cheng FC; Shu KH; Wu MJ
    Am J Nephrol; 1997; 17(6):541-2. PubMed ID: 9426852
    [No Abstract]   [Full Text] [Related]  

  • 2. Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients.
    Balaskas EV; Bamihas GI; Karamouzis M; Voyiatzis G; Tourkantonis A
    Nephron; 1998; 78(4):395-402. PubMed ID: 9578065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of Na-K-ATPase inhibitors to blood-pressure regulation in continuous ambulatory peritoneal dialysis and hemodialysis.
    Weiler EW; Saldanha LF; Khalil-Manesh F; Prins BA; Purdy RE; Gonick HC
    J Am Soc Nephrol; 1996 Mar; 7(3):454-63. PubMed ID: 8704112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of continuous ambulatory peritoneal dialysis (CAPD) in a program for the treatment of chronic renal insufficiency. Problems posed by transfer of CAPD to transplantation or hemodialysis].
    Canaud B; Mion C
    Nephrologie; 1995; 16(1):129-35. PubMed ID: 7700413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral serotonergic system in hemodialyzed and peritoneally dialyzed patients.
    Malyszko J; Pawlak D; Malyszko J; Buczko W; Myśliwiec M
    Nephron; 2000 Nov; 86(3):396-7. PubMed ID: 11096322
    [No Abstract]   [Full Text] [Related]  

  • 6. [Protein-bound uremic toxins: efficacy of elimination during hemodialysis and CAPD].
    Krajewska M; Weyde W; Klinger M
    Pol Arch Med Wewn; 2003 Apr; 109(4):411-5. PubMed ID: 12931494
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of erythropoietin in the reversal of anemia of renal failure with continuous ambulatory peritoneal dialysis.
    Chandra M; McVicar M; Clemons G; Mossey RT; Wilkes BM
    Nephron; 1987; 46(3):312-5. PubMed ID: 3627325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased uroporphyrinogen decarboxylase activity in patients with end-stage renal disease undergoing hemodialysis.
    Mamet R; Gafter U; Korzets A; Schoenfeld N
    Nephron; 1995; 70(2):202-6. PubMed ID: 7566304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole blood serotonin levels are markedly elevated in patients on dialytic therapy.
    Kerr PG; Argiles A; Mion C
    Am J Nephrol; 1992; 12(1-2):14-8. PubMed ID: 1415359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of human atrial natriuretic factor in patients treated by hemodialysis and continuous ambulatory peritoneal dialysis.
    Ando R; Matsuda O; Miyake S; Yoshiyama N
    Nephron; 1988; 50(3):225-8. PubMed ID: 2976122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of NT-proBNP levels in hemodialysis versus peritoneal dialysis patients.
    Ludka O; Spinar J; Tomandl J; Konecny T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):325-30. PubMed ID: 23154540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatographic characterization of neurophysins in chronic renal failure.
    Amico JA; Silver MR; Finn FM; Robinson AG
    J Lab Clin Med; 1987 Oct; 110(4):439-47. PubMed ID: 3655523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiographic evaluation in long-term continuous ambulatory peritoneal dialysis compared with the hemodialysis patients.
    Takeda K; Nakamoto M; Baba M; Tanaka T; Yasunaga C; Nishihara G; Matsuo K; Urabe M
    Clin Nephrol; 1998 May; 49(5):308-12. PubMed ID: 9617495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dosage of erythropoietin in children treated with hemodialysis and continuous ambulatory peritoneal dialysis].
    Sieniawska M; Roszkowska-Blaim M
    Pediatr Pol; 1995 Dec; 70(12):1023-8. PubMed ID: 8649941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.
    Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ
    Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of latamoxef on platelet aggregation in hemodialysis and continuous ambulatory peritoneal dialysis (CAPD) patients].
    Inoue T; Sakaguchi K; Yoshida K; Imai T; Kajimoto Y; Shirai D
    Nihon Jinzo Gakkai Shi; 1986 Feb; 28(2):177-83. PubMed ID: 3735768
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma amino acids in dialyzed children: comparison of hemodialysis and continuous ambulatory peritoneal dialysis].
    Perfumo F; Verrina E; Romano C; Cerone R; Caruso U; Gusmano R
    Pediatr Med Chir; 1986; 8(3):341-5. PubMed ID: 3786196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxalate removal by differing dialysis techniques.
    Dell'Aquila R; Feriani M; Mascalzoni E; Bragantini L; Ronco C; La Greca G
    ASAIO J; 1992; 38(4):797-800. PubMed ID: 1450473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavior of beta 2-microglobulin in patients with chronic renal failure undergoing hemodialysis, hemodiafiltration and continuous ambulatory peritoneal dialysis (CAPD).
    Blumberg A; Bürgi W
    Clin Nephrol; 1987 May; 27(5):245-9. PubMed ID: 3297439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.